V. Wayne Engleman

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

V. Wayne Engleman, G. Allen Nickols, F. Patrick Ross et al. · Journal of Clinical Investigation · 1997 · 287 citations · Full text

Sclerostin, Bone Resorption, Orthopaedic Surgery +13

Nerve Growth Factor Facilitates Regeneration across Nerve Gaps: Morphological and Behavioral Studies in Rat Sciatic Nerve

Albert Derby, V. Wayne Engleman, Gregory E. Frierdich et al. · Experimental Neurology · 1993 · 136 citations

Behavioral Studies, Nerve Gaps, Neuroregeneration +9

Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.

Barbara A. Crippes, V. Wayne Engleman, Steven L. Settle et al. · Endocrinology · 1996 · 80 citations

Mechanobiology, Cell Surface Integrin, Medicine +15

SC-54684A: An Orally Active Inhibitor of Platelet Aggregation

Nancy S. Nicholson, Susan G. Panzer‐Knodle, Anita K. Salyers et al. · Circulation · 1995 · 65 citations

Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone

C.P. Carron, D. M. Meyer, V. Wayne Engleman et al. · Journal of Endocrinology · 2000 · 54 citations · Full text

Sclerostin, Pharmacotherapy, Bone Surfaces +20